Pfizer
'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion
Founder of the Genesis Prize Stan Polovets on why your seventies and eighties – and even nineties – can be your most impactful years.
Grapevine, November 30, 2025: Mamdani complexities
MBS’s first Washington trip since 2018 brings new investments
Former Pfizer chief scientist joins Immunai’s board of directors
Pfizer's COVID vaccine factory: Witnessing a modern miracle
Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.
Sleeping less than six hours will decrease vaccine effectiveness - study
The multi-institution study, published in the peer-reviewed academic journal Current Biology, sheds light on the link between sleep duration and antibody response.
mRNA could make flu vaccines more effective - here's how
The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.
Could vaccines be a cure for antibiotic-resistant bacteria?
Israeli scientists announce 100% effectiveness of mRNA vaccine against Black Plague-causing bacteria in preclinical trial performed on mice.
‘Hindsight is 20/20’: Israel's lessons after 3 years of COVID-19
HEALTH AFFAIRS: On Israel’s three-year COVID anniversary, ‘czars’ look forward and back.
US Parkinson's disease incidence far higher than earlier estimates -study
Analysis of insurance claims and population growth indicates higher numbers than previously thought - and they will continue to rise.
NYSE gala honors Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli Group
Israel Day, organized and hosted by the America-Israel Friendship League and Israeli Mapped in NY annually holds the event in collaboration with the NY Stock Exchange to honor Israeli tech
Couple who stopped COVID-19 promise cancer vaccine by 2030
These two doctors developed one of the vaccines against COVID-19. It's believed that they will succeed in developing a vaccine against specific cancers in the next eight years.
New Omicron vaccines proven safe and effective
The new boosters are suited to two COVID-19 strains of the Omicron virus variant that represents the vast majority of infections, according to the FDA.
COVID: Omicron BA.2 infection after vaccine can protect from BA.4/BA.5 - study
Breakthrough infections of COVID-19 Omicron BA.2 in people who have received the Pfizer/BioNTech vaccine have more antibodies against the dominant BA.4/BA.5 descendants.
